Quadruplet Shows 'Excellent Activity' in Myeloma Patients Who Defer HSCT
(MedPage Today) -- Adding the CD38 monoclonal antibody isatuximab (Sarclisa) to a backbone of carfilzomib (Kyprolis), lenalidomide (Revlimid), and dexamethasone (KRd) induced deep and durable responses in a multiple myeloma study of untreated transplant...